Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Phase 1 / 2 Study to Evaluate SNDX- 6352 in Subjects With Active cGVHD
Multiple Cancer Types
This is a Phase 1 / 2, Open-label, Dose Escalation study to investigate SNDX-6352 in subjects with active cGVHD.
Hematologic,
Phase I
I
Kitko, Carrie
NCT03604692
VICCCTTP18109
